Skip to main content
logo
Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
102.50
-2.00 (-1.91%)
Aug 19, 2026, 1:30 PM CST

TPE:6919 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
162,539240,25094,36523,5407,528-
Market Cap Growth
-27.73%154.60%300.87%212.69%--
Enterprise Value
158,600233,73884,68522,6946,297-
Last Close Price
104.50155.0061.5019.136.11-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
27.0464.85----
PS Ratio
5529.866316.212123.71604.64587.23-
PB Ratio
17.6525.539.736.296.47-
P/TBV Ratio
17.6525.539.736.296.47-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-6145.021905.86582.91491.18-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.0100.000.010.030.06
Net Debt / Equity Ratio
-0.43-0.52-1.00-0.99-0.93-0.87
Net Debt / EBITDA Ratio
4.877.0913.887.483.582.60
Net Debt / FCF Ratio
13.1210.9818.148.534.214.44
Asset Turnover
0.000.000.010.020.010.03
Inventory Turnover
1.424.017.045.992.252.41
Quick Ratio
57.87106.97183.4250.4823.0415.00
Current Ratio
60.03109.71184.0250.8123.4115.26
Return on Equity (ROE)
-2.77%-3.68%-8.76%-19.92%-31.64%-64.89%
Return on Assets (ROA)
-5.49%-4.59%-6.59%-12.68%-20.53%-30.68%
Return on Capital Employed (ROCE)
-8.90%-7.50%-7.40%-13.70%-27.00%-34.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-0.16%-0.15%-0.62%-2.08%-3.80%-
FCF Yield
-0.18%-0.18%-0.56%-1.84%-3.41%-
Buyback Yield / Dilution
-3.04%-7.94%-15.40%-5.77%-27.35%-23.49%